Categories
Marijuana Stocks News

$MDBX Client Awarded Illinois Medical Marijuana Dispensary Authorization

Medbox Client Awarded Illinois Medical Marijuana Dispensary Authorization

LOS ANGELES–(BUSINESS WIRE)–

Medbox, Inc. (OTCQB:MDBX) (www.medbox.com), a leading licensing, infrastructure and security specialist, patented technology provider, and partner to the cannabis industry, is pleased to announce that on February 3, 2015, its client, Nature’s Treatment of Illinois, was awarded a medical marijuana dispensary authorization from the state of Illinois.

Medbox was engaged by Nature’s Treatment to advise and lead the application process, and following the award, Nature’s Treatment has subsequently engaged Medbox Management Services, Inc., a wholly owned Medbox subsidiary, to provide ongoing management services. This will include identifying qualified state-screened third party operators who will assume operation of the medical marijuana dispensary, with professional oversight being provided by Medbox.

The award to Nature’s Treatment from the Illinois Department of Financial and Professional Regulation stated in part, “After a review of your Medical Cannabis Dispensary Application, the Division has selected your application as the most qualified in District 7 in connection with the Compassionate Use of Medical Cannabis Pilot Program Act 410 ILCS 130.”

Matt Stern, prominent local business owner and Nature’s Treatment partner stated, “I am excited to partner with Medbox in this very unique opportunity. The Illinois selection was very competitive and our local focus proposal on economic development and local jobs coupled with the Medbox technology and experience, will benefit the community and the patients in the Rock Island area.”

Medbox CEO, Guy Marsala commented, “It’s exciting to take this significant step in the process of opening one of the first medical marijuana dispensaries in Illinois. Once again Medbox has demonstrated our expertise in achieving state license awards for our clients, by working with state regulatory agencies to meet or exceed all standards of compliance and operational excellence.”

About Medbox, Inc.

Medbox, Inc. (“MDBX” or the “Company”) is the leading dispensary infrastructure and licensing specialist, patented technology provider, and partner to the cannabis industry. Headquartered in Los Angeles, CA, Medbox, through its wholly owned subsidiary, Medicine Dispensing Systems, offers its patented systems, software and consulting services to pharmacies, alternative medicine dispensaries and local governments in the U.S. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers an industry award winning medical line of vaporizer products. Medbox, through its newly established subsidiaries, is also developing ancillary services tailored to the alternative medicine industry, including real estate acquisitions and subsequent lease programs to alternative medicine dispensaries and cultivation centers, and alternative medicine dispensary and cultivation management services.

Forward-Looking Statements

The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.

Contact Information

Investor Relations:
Stephen Hart
Hayden IR
917-658-7878
hart@haydenir.com

Medbox:
For more information on Medbox, please call (800) 762-1452.

Contact:
Hayden IR
Investor Relations:
Stephen Hart, 917-658-7878
hart@haydenir.com
or
Medbox:
800-762-1452

By J. Phillip

Coming from Miami FL, Jonathan Phillip or (J. Phillip) is a social media marketer and currently head of PR and social media management for MarijuanaStocks.com. When working with clients in various sectors Jonathan will use his expertise and knowledge to make sure the correct audience is viewing and engaging with your content product or service. Jonathan is a self-taught marketer and entrepreneur learning from the best and sharpening his skills with each project.

Leave a Reply

Your email address will not be published.